# ABT-888 With Modified FOLFOX6 in Patients With Metastatic Pancreatic Cancer

> **NCT01489865** · PHASE1,PHASE2 · COMPLETED · sponsor: **Georgetown University** · enrollment: 64 (actual)

## Conditions studied

- Metastatic Pancreatic Cancer

## Interventions

- **DRUG:** ABT-888
- **DRUG:** mFOLFOX-6

## Key facts

- **NCT ID:** NCT01489865
- **Lead sponsor:** Georgetown University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01-03
- **Primary completion:** 2018-12-26
- **Final completion:** 2023-12-07
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2025-11-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01489865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01489865, "ABT-888 With Modified FOLFOX6 in Patients With Metastatic Pancreatic Cancer". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01489865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*